Business
GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals
GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals\nThe new license provides access to the largest growing sectors in the cannabis industry. Multiple new brands for both medical and recreational markets being prepped for retail sales.\nPR Newswire\nLAS VEGAS, Sept. 25, 2018\n\n\n\nLAS VEGAS, Sept. 25, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has been granted a recreational production license for the manufacture of cannabis oils.  Oils are the base ingredient for vape products, tinctures, edibles, and nutraceutical formulations. \n\n \n \n\n \nThe Company received its medical marijuana production license on February 2, 2018. The State of Nevada instructed them to apply for the recreational license in June, for upgraded licenses.  The Company's anticipated revenues from extracted and infused products were delayed by six months.  Now, with the issuance of the recreational oil production license, the Company can begin selling its tinctures, oils, vape pens and edibles with estimated revenue starting at around $100,000 per month and growing to at least $300,000 per month. \nThe new product lines will be the first step in delivering therapeutic formulations directly into the hands of patients through the retail dispensaries in Nevada. In anticipation of receiving the recreational production license, product development and testing has been ongoing through the use of the current medical production license. Now these products are planned for retail dispensary sales as recreational products in Fall 2018.\nThe first product to go to retail will be WOKE, a single strain, whole plant extracted product line with full spectrum CBD, cold pressed hemp oil, and natural flavors. By pressing out the rosin of a single strain to retain all of the cannabinoids and terpenes, and adding 99%+ pure CBD isolate, cold p...